| Ticker Details |
|
Biodesix, Inc. Common Stock
|
| IPO Date: |
November 1, 2020 |
| Sector: |
Healthcare |
| Industry: |
Healthcare Providers and Services |
| Market Cap: |
$104.94M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 4.60%
|
| Avg Daily Range (30 D): |
$0.63 | 6.51%
|
| Avg Daily Range (90 D): |
$0.41 | 5.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
2.66M |
| Avg Daily Volume (90 D): |
.99M |
| Trade Size |
| Avg Trade Size (Sh.): |
75 |
| Avg Trade Size (Sh.) (30 D): |
112 |
| Avg Trade Size (Sh.) (90 D): |
108 |
| Institutional Trades |
| Total Institutional Trades: |
40 |
| Avg Institutional Trade: |
$1.78M |
| Avg Institutional Trade (30 D): |
$1.27M |
| Avg Institutional Trade (90 D): |
$1.35M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.84M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
22.86K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.16
|
$-.08
|
$-.08
|
|
Diluted EPS
|
$-1.16
|
$-.08
|
$-.08
|
|
Revenue
|
$21.77M
|
$20.02M
|
$17.96M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-8.72M
|
$-11.47M
|
$-11.1M
|
|
Operating Income / Loss
|
$-7.05M
|
$-9.72M
|
$-9.14M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-4.12M
|
$3.13M
|
$-8.64M
|
|
PE Ratio
|
|
|
|
|
|
|